| #579 |
Michael C. Zody |
The Broad Institute |
1 |
| #579 |
Melissa Youngju Byun |
Google |
1 |
| #579 |
Matthew T. Klug |
MIT |
1 |
| #579 |
Alex Broerman |
Herman Miller |
1 |
| #579 |
Michael Liebson |
Oracle |
1 |
| #579 |
William Chutkow |
Arrowhead Pharmaceuticals |
1 |
| #579 |
Larry Alexander Gaither |
Novartis Ag |
1 |
| #579 |
Kimberly Murdaugh |
Harvard University |
1 |
| #579 |
Samuel Weiss |
Microsoft |
1 |
| #579 |
Ulric J. Ferner |
MIT |
1 |
| #579 |
Avram Lev Robinson-Mosher |
Harvard University |
1 |
| #579 |
Rose L. Szabady |
Vedanta Biosciences |
1 |
| #579 |
Peter T. Sage |
Harvard University |
1 |
| #579 |
Jade Kessler |
Microsoft |
1 |
| #579 |
Scott D. Cowen |
Nimbus Lakshmi |
1 |
| #579 |
Andrew Milia |
— |
1 |
| #579 |
Stavroula Morti |
Baxter International |
1 |
| #579 |
Ehsan Rasekh |
Ansys |
1 |
| #579 |
Adam Shabshelowitz |
MIT |
1 |
| #579 |
Shahar Alon |
MIT |
1 |
| #579 |
Albert Redo-Sanchez |
MIT |
1 |
| #579 |
Camille Huin |
Analog Devices |
1 |
| #579 |
Nagesh K. Mahanthappa |
Scholar Rock |
1 |
| #579 |
Umberto Scarfogliero |
Rethink Robotics Gmbh |
1 |
| #579 |
Avinash Khanna |
Constellation Pharmaceuticals |
1 |
| #579 |
Andrew Vanslette |
Ocular Therapeutix |
1 |
| #579 |
Claudio V. Di Leo |
Apple |
1 |
| #579 |
Lauren Dell Zarzar |
MIT |
1 |
| #579 |
Edmund Golaski |
Intel |
1 |
| #579 |
Preethi Raghavan |
IBM |
1 |
| #579 |
Christopher Vincent Poulton |
Analog Photonics |
1 |
| #579 |
Yedidya Dotan |
Emc |
1 |
| #579 |
Pavitra Krishnaswamy |
MIT |
1 |
| #579 |
Jessica McGrath |
Dsm Ip Assets B.V. |
1 |
| #579 |
Lucas C. Cahill |
MIT |
1 |
| #579 |
Christopher Moss |
Bae Systems Information And Electronic Systems Integration |
1 |
| #579 |
Seth Kasper |
Haemonetics |
1 |
| #579 |
Nicolas VOGEL |
Harvard University |
1 |
| #579 |
Hongtao Qiao |
Mitsubishi Electric |
1 |
| #579 |
Glenn KnicKrehm |
Constellation Productions |
1 |
| #579 |
Steve Bottega |
Aveo Pharmaceuticals |
1 |
| #579 |
Anthony D. Keefe |
X-Chem |
1 |
| #579 |
Sameer Ahmed Sabir |
Kci Licensing |
1 |
| #579 |
Michael Glenn Campbell |
MIT |
1 |
| #579 |
Kelly R. Stevens |
MIT |
1 |
| #579 |
Ravi Tejwani |
IBM |
1 |
| #579 |
Douglas Scott Jacobs |
GE |
1 |
| #579 |
Ashok R. Subramanian |
Aspen Technology |
1 |
| #579 |
James D. Krieger |
MIT |
1 |
| #579 |
Uddhav Kumar Shigdel |
Revolution Medicines |
1 |